NCT06548256Recruiting
The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 12 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is an open-label, single-center, non-randomized study to assess the efficacy of Clostridium Butyricum Miyairi on the motor and non-motor symptoms of Parkinson's disease
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- First submitted
- 16 May 2024
- Start date
- 31 Oct 2023
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Diseases
- Parkinson disease
- NCT number
- NCT06548256
What you commit to
- Study type: Interventional
- Planned participants: 400
- From 31 Oct 2023 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- People with Parkinson's disease Dementia, or Lactose Intolerance
Who the study is looking for
- Male or female over 20 years old, diagnosed with Parkinson's disease.
Age in the registry: 20 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kaohsiung Medical Univeristy Hospital Coordinator of this site? Confirm its status | Kaohsiung City | Taiwan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.